- Home
- MP vs HOLX Comparison
MP vs HOLX Comparison
Compare MP & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MP
- HOLX
- Stock Information
- Founded
- MP 2017
- HOLX 1985
- Country
- MP United States
- HOLX United States
- Employees
- MP 804
- HOLX N/A
- Industry
- MP Metal Mining
- HOLX Medical Electronics
- Sector
- MP Basic Materials
- HOLX Health Care
- Exchange
- MP Nasdaq
- HOLX Nasdaq
- Market Cap
- MP 11.2B
- HOLX 14.8B
- IPO Year
- MP N/A
- HOLX 1990
- Fundamental
- Price
- MP $63.59
- HOLX $64.45
- Analyst Decision
- MP Buy
- HOLX Buy
- Analyst Count
- MP 8
- HOLX 13
- Target Price
- MP $61.00
- HOLX $76.27
- AVG Volume (30 Days)
- MP 9.0M
- HOLX 1.5M
- Earning Date
- MP 11-06-2025
- HOLX 11-03-2025
- Dividend Yield
- MP N/A
- HOLX N/A
- EPS Growth
- MP N/A
- HOLX N/A
- EPS
- MP N/A
- HOLX 2.41
- Revenue
- MP $242,116,000.00
- HOLX $4,038,900,000.00
- Revenue This Year
- MP $41.97
- HOLX $3.37
- Revenue Next Year
- MP $145.91
- HOLX $4.46
- P/E Ratio
- MP N/A
- HOLX $26.70
- Revenue Growth
- MP 39.42
- HOLX 1.29
- 52 Week Low
- MP $13.40
- HOLX $51.90
- 52 Week High
- MP $82.50
- HOLX $84.39
- Technical
- Relative Strength Index (RSI)
- MP 45.68
- HOLX 38.24
- Support Level
- MP $61.60
- HOLX $65.37
- Resistance Level
- MP $65.62
- HOLX $66.97
- Average True Range (ATR)
- MP 3.38
- HOLX 1.11
- MACD
- MP -1.37
- HOLX -0.28
- Stochastic Oscillator
- MP 15.60
- HOLX 1.93
About MP MP Materials Corp.
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.